Sales & Marketing Veeva Commercial Summit '23: The power of connectivity Veeva Systems’ Commercial Summit returned to Madrid for 2023, with over 1,500 life sciences industry professionals in attendance.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.